Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry

Folia Histochemica et Cytobiologica

Volumn 50, Issue 3, 2012, Pages 368-374

  Yousefi, Zahra ^a   Sarvari, Jamal ^a,b,c   Nakamura, Kazuyuki ^c   Kuramitsu, Yasuhiro ^c   Ghaderi, Abbas ^a   Mojtahedi, Zahra ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Biomarkers; Conditioned media; Lung cancer cell lines; Mass spectrometry; Secretome

Indexed keywords

ALPHA ENOLASE; CHLORIDE INTRACELLULAR CHANNEL PROTEIN 4; DICKKOPF 1 PROTEIN; EPIDERMAL FATTY ACID BINDING PROTEIN; INTERLEUKIN 25; INTERLEUKIN 6; PEROXIREDOXIN 1; PROTEIN PGP9.5; PROTEOME; STATHMIN; STRESS INDUCED PHOSPHOPROTEIN 1; TRANSGELIN 2; TRIOSEPHOSPHATE ISOMERASE; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BODY FLUID COMPARTMENT; CANADA; CANCER CELL CULTURE; CELL DEATH; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; HUMAN; HUMAN CELL; IRAN; LARGE CELL CARCINOMA; LIQUID CHROMATOGRAPHY; LUNG CARCINOMA; MALE; METABOLIC REGULATION; OXIDATION REDUCTION STATE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FOLDING; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; TUMOR MICROENVIRONMENT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 84867802047     PISSN: 02398508     EISSN: 18975631     Source Type: Journal    
DOI: 10.5603/FHC.2012.0050     Document Type: Article

References (42)

1. Pavlou MP, Diamandis EP. The cancer cell secretome: A good source for discovering biomarkers? Proteomics. 2010;2:1-11.
2. Xue H, Lu B, Lai M. The cancer secretome: a reservoir of biomarkers. J Transl Med. 2008;6:52.
3. Wu CC, Hsu CW, Chen CD et al. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics. 2010;9:1100-1117.
4. Cole SP, Campling BG, Dexter DF, Holden JJ, Roder JC. Establishment of a human large cell lung tumor line (QUDB) with metastatic properties in athymic mice. Cancer. 1986;58:917-923.
5. Sharifzadeh S, Owji SM, Pezeshki AM et al. Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation. Pathol Oncol Res. 2004;10:225-230.
6. Naumnik W, Nilklińska W, Ossolińska M, Chyczewska E. Serum levels of HMGB1, survivin, and VEGF in patients with advanced non-small cell lung cancer during chemotherapy. Folia Histochem Cytobiol. 2009;47:703-709.
7. Zhang Y, Li M, Liu Y, Han N, Zhang K, Xiao T et al. ENO1 protein levels in the tumor tissues and circulating plasma samples of non-small cell lung cancer patients]. Zhongguo Fei Ai Za Zhi. 2010;13:1089-1093.
8. Chang JW, Lee SH, Jeong JY et al. Peroxiredoxin-I is an autoimmunogenic tumor antigen in non small cell lung cancer. FEBS Lett. 2005;597:2873-2877.
9. Sheng SL, Huang G, Yu B, Qin WX. Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem. 2009;55:1656-1564.
10. Katsumata N, Eguchi K, Fukuda M et al. Serum levels of cytokines in patients with untreated primary lung cancer. Clin Cancer Res. 1996;2:553-559.
11. Kim JE, Koo KH, Kim YH, Park YG. Identification of potential lung cancer biomarkers using an in vitro carcinogenesis model. Exp Mol Med. 2008;40:709-720.
12. Zhang XZ, Xiao ZF, Li C et al. Triosephosphate isomerase and peroxiredoxin 6, two novel serum markers for human lung squamous cell carcinoma. Cancer Sci. 2009;100:2396-2401.
13. Hida T, Kuwabara M, Ariyoshi Y et al. Serum glutathione S-transferase-pi level as a tumor marker for non-small cell lung cancer. Potential predictive value in chemotherapeutic response. Cancer. 1994;73:1377-1382.
14. Chen G, Gharib TG, Wang H et al. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci USA. 2003;100:13537-13542.
15. Yazawa T, Sato H, Shimoyamada H et al. Neuroendocrine cancer-specific up-regulating mechanism of insulin-like growth factor binding protein-2 in small cell lung cancer. Am J Pathol. 2009;175:976-987.
16. Tan F, Jiang Y, Sun N et al. Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis. Mol Cell Proteomics. 2012;11:M111.008821.
17. Sun S, Poon RT, Lee NP, Yeung C, Chan KL, Ng IO et al. Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (< or = 2 cm). J Proteome Res. 2010;9:1923-1930.
18. Shibuya A, Ikewaki N. High serum glyceraldehyde-3-phosphate dehydrogenase levels in patients with liver cirrhosis. Hepatol Res. 2002;22:174-179.
19. Roessler M, Rollinger W, Mantovani-Endl L et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics. 2006;5:2092-2101.
20. Ren H, Du N, Liu G et al. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J Gastroenterol. 2006;12:2789-2792.
21. Wang TH, Chao A, Tsai CL et al. Stress-induced phosphoprotein 1 as a secreted biomarker for human ovarian cancer promotes cancer cell proliferation. Mol Cell Proteomics. 2010;9:1873-1884.
22. Jmal A, Abdennebi M, Boussen H et al. [Serum lactate dehydrogenase and its isoenzymes in nasopharyngeal carcinoma in Tunisia]. Tunis Med. 2005;83:218-220.
23. Le Naour F, Misek DE, Krause MC et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res. 2001;7:3328-3335.
24. Chang YH, Wu CC, Chang KP, Yu JS, Chang YC, Liao PC. Cell secretome analysis using hollow fiber culture system leads to the discovery of CLIC1 protein as a novel plasma marker for nasopharyngeal carcinoma. J Proteom Res. 2009;8:5465-5474.
25. Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Report. 2002;7:1-8.
26. Yeung DC, Xu A, Tso AW et al. Circulating levels of adipocyte and epidermal fatty acid-binding proteins in relation to nephropathy staging and macrovascular complications in type 2 diabetic patients. Diabets Care. 2009;32:132-134.
27. Cauwe B, Martens E, Van den Steen PE et al. Adenylyl cyclase-associated protein-1/CAP1 as a biological target substrate of gelatinase B/MMP9. Exp Cell Res. 2008;314:2739-2749.
28. Bell LN, Theodorakis JL, Vuppalanchi R et al. Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease. Hepatology. 2010;51:111-120.
29. Ritter M, Buechler C, Boettcher A et al. Cloning and characterization of a novel apolipoprotein A-I binding protein, AI-BP, secreted by cells of the kidney proximal tubules in response to HDL or ApoA-I. Genomics. 2002;79:693-702.
30. Hoyt CS 3rd, Billson FA. Low-carbohydrate diet optic neuropathy. Med J Aust. 1977;1:65-166.
31. Tumani H, Shen G, Peter JB, Brück W. Glutamine synthetase in cerebrospinal fluid, serum, and brain: a diagnostic marker for Alzheimer disease? Arch Neurol. 1999;56:1241-1246.
32. Mohan H, Krumbholz M, Sharma R et al. Extracellular matrix in multiple sclerosis lesions: Fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol. 2010;20:966-975.
33. Eaton RH, Moss DW. Alkaline orthophosphatase and inorganic pyrophosphatase activities in human serum. Nature. 1967; 214:842-843.
34. Waerner T, Alacakaptan M, Tamir I et al. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell. 2006;10:227-239.
35. Reynolds JM, Angkasekwinai P, Dong C. IL-17 family member cytokines: regulation and function in innate immunity. Cytokine Growth Factor Rev. 2010; 21:413-423.
36. Bührens RI, Amelung JT, Reymond MA, Beshay M. Protein expression in human non-small cell lung cancer: a systematic database. Pathobiology. 2009;76:277-285.
37. Rho JH, Roehrl MH, Wang JY. Tissue proteomics reveals differential and compartment-specific expression of the homologs transgelin and transgelin-2 in lung adenocarcinoma and its stroma. J Proteome Res. 2009;8:5610-5618.
38. Li LS, Kim H, Rhee H et al. Proteomic analysis distinguishes basaloid carcinoma as a distinct subtype of nonsmall cell lung carcinoma. Proteomics. 2004;4:3394-3400.
39. Upton MP, Hirohashi S, Tome Y, Miyazawa N, Suemasu K, Shimosato Y. Expression of vimentin in surgically resected adenocarcinomas and large cell carcinomas of lung. Am J Surg Pathol. 1986;10:560-567.
40. Rubporn A, Srisomsap C, Subhasitanont P et al. Comparative proteomic analysis of lung cancer cell line and lung fibroblast cell line. Cancer Genomics Proteomics. 2009; 6:229-237.
41. Singer S, Malz M, Herpel E et al. Coordinated expression of stathmin family members by far upstream sequence elementbinding protein-1 increases motility in non-small cell lung cancer. Cancer Res. 2009;69:2234-2243.
42. Robert C, Bolon I, Gazzeri S, Veyrenc S, Brambilla C, Brambilla E. Expression of plasminogen activator inhibitors 1 and 2 in lung cancer and their role in tumor progression. Clin Cancer Res. 1999;5:2094-2102.